These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2447714)

  • 21. The voltage-dependent effect of 1,4-dihydropyridine enantiomers on Ca channels in cardiac cells.
    Kokubun S; Porzig H; Prod'hom B; Reuter H
    Jpn Heart J; 1986 Nov; 27 Suppl 1():57-63. PubMed ID: 2434682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
    Thomas G; Gross R; Schramm M
    J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid cells express dihydropyridine-sensitive cation currents and L-type calcium channel subunits.
    Chang W; Pratt SA; Chen TH; Tu CL; Mikala G; Schwartz A; Shoback D
    Am J Physiol Endocrinol Metab; 2001 Jul; 281(1):E180-9. PubMed ID: 11404236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereochemical requirements for the mineralocorticoid receptor antagonist activity of dihydropyridines.
    Arhancet GB; Woodard SS; Dietz JD; Garland DJ; Wagner GM; Iyanar K; Collins JT; Blinn JR; Numann RE; Hu X; Huang HC
    J Med Chem; 2010 May; 53(10):4300-4. PubMed ID: 20408553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes.
    Maan AC; Hosey MM
    Circ Res; 1987 Sep; 61(3):379-88. PubMed ID: 2441891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydropyridine Ca2+ agonists and channel blockers interact in the opposite manner with photogenerated unpaired electrons.
    Marinov BS; Saxon ME
    FEBS Lett; 1985 Jul; 186(2):251-4. PubMed ID: 2408923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptor.
    Langs DA; Kwon YW; Strong PD; Triggle DJ
    J Comput Aided Mol Des; 1991 Apr; 5(2):95-106. PubMed ID: 1651370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enantiomer separation of dihydropyridine calcium antagonists with cyclodextrins as chiral selectors: structural correlation.
    Gilar M; Uhrová M; Tesarová E
    J Chromatogr B Biomed Appl; 1996 May; 681(1):133-41. PubMed ID: 8798922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for dihydropyridine calcium channel blockers in plasma by automated solid-phase extraction and liquid chromatography/tandem mass spectrometry.
    Mueller CA; González AB; Weinmann W
    J Mass Spectrom; 2004 Jun; 39(6):639-46. PubMed ID: 15236302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel.
    Triggle DJ; Janis RA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S949-55. PubMed ID: 6085383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of the dihydropyridine Ca2+ antagonist felodipine. Dihydropyridine binding prerequisites assessed from crystallographic data.
    Fossheim R
    J Med Chem; 1986 Feb; 29(2):305-7. PubMed ID: 3005572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
    Vo D; Matowe WC; Ramesh M; Iqbal N; Wolowyk MW; Howlett SE; Knaus EE
    J Med Chem; 1995 Jul; 38(15):2851-9. PubMed ID: 7543577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Permanently charged chiral 1,4-dihydropyridines: molecular probes of L-type calcium channels. Synthesis and pharmacological characterization of methyl(omega-trimethylalkylammonium) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate iodide, calcium channel antagonists.
    Peri R; Padmanabhan S; Rutledge A; Singh S; Triggle DJ
    J Med Chem; 2000 Jul; 43(15):2906-14. PubMed ID: 10956198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Competitive binding experiments reveal differential interactions for dihydropyridine calcium channel activators and antagonists at dihydropyridine receptors on mouse brain membranes.
    O'Neill SK; Triggle CR; Bolger GT
    Can J Physiol Pharmacol; 1994 Jul; 72(7):738-45. PubMed ID: 7530159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.
    Kokubun S; Prod'hom B; Becker C; Porzig H; Reuter H
    Mol Pharmacol; 1986 Dec; 30(6):571-84. PubMed ID: 2431263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular approach to the calcium channel.
    Glossmann H; Ferry DR; Goll A; Linn T
    Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists.
    Glossmann H; Linn T; Rombusch M; Ferry DR
    FEBS Lett; 1983 Aug; 160(1-2):226-32. PubMed ID: 6309565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand.
    Ferry DR; Goll A; Glossmann H
    Biochem J; 1987 Apr; 243(1):127-35. PubMed ID: 2440422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine.
    Triggle AM; Shefter E; Triggle DJ
    J Med Chem; 1980 Dec; 23(12):1442-5. PubMed ID: 6256552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters.
    Atwal KS; Bergey JL; Hedberg A; Moreland S
    J Med Chem; 1987 Apr; 30(4):635-40. PubMed ID: 2435903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.